- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/54 - Interleukins [IL]
Patent holdings for IPC class C07K 14/54
Total number of patents in this class: 3881
10-year publication summary
|
119
|
157
|
205
|
233
|
335
|
353
|
349
|
407
|
420
|
263
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1153 |
124 |
| Regeneron Pharmaceuticals, Inc. | 4312 |
78 |
| Xencor, Inc. | 396 |
62 |
| Altor BioScience, LLC | 76 |
58 |
| Immunitybio, Inc. | 390 |
53 |
| Board of Regents, The University of Texas System | 5841 |
45 |
| The Board of Trustees of the Leland Stanford Junior University | 6447 |
40 |
| The Trustees of the University of Pennsylvania | 4335 |
40 |
| Modernatx, Inc. | 1285 |
38 |
| Obsidian Therapeutics, Inc. | 78 |
34 |
| City of Hope | 996 |
33 |
| Genentech, Inc. | 3988 |
31 |
| Memorial Sloan-Kettering Cancer Center | 1940 |
30 |
| National University of Singapore | 2460 |
30 |
| Yale University | 2400 |
30 |
| Deka Biosciences, Inc. | 43 |
29 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2866 |
28 |
| Cytune Pharma | 39 |
25 |
| The Regents of the University of California | 20035 |
23 |
| Janssen Biotech, Inc. | 1552 |
23 |
| Other owners | 3027 |